An international research team has demonstrated that a new plant-derived drug can block the progression of multiple sclerosis (MS).
University of Queensland researcher Dr Christian Gruber said the breakthrough could be a step forward in preventing and treating MS and other autoimmune diseases.
“This is a really exciting discovery because it may offer a whole new quality of life for people with this debilitating disease,” he said.
The new drug is expected to be taken by mouth, in contrast to some current MS treatments where patients need to have frequent injections.
MS is a chronic incurable condition marked by attacks that bring gradual deterioration in the patient’s health. About 23,000 people are affected in Australia and 2.5 million worldwide.
Dr Gruber said the new drug – named T20K – was extracted from a traditional medicinal plant, the Oldenlandia affinis.
The drug treatment had been successful in an animal model, and patent applications filed in several countries.
“Phase one clinical trials could begin as early as 2018,” Dr Gruber said.
“Licences have been assigned to Cyxone, a company established last year to develop this new class of drugs for the treatment of autoimmune diseases.
“Cyxone’s immediate focus is on bringing T20K through the pre-clinical program required for delivering a safe, orally active drug.”
Dr Gruber said the new treatment arose from a synthesised plant peptide, a class of drugs known as cyclotides.
“Cyclotides are present in a range of common plants, and they show significant potential for the treatment of auto immune diseases,” he said.
“The T20K peptides exhibit extraordinary stability and chemical features that are ideally what you want in an oral drug candidate.”
The international research team demonstrated in an animal model that T20K stopped progression in the normal clinical symptoms of MS.
The Latest on: Multiple sclerosis
via Google News
The Latest on: Multiple sclerosis
- Disrupted principal network organisation in multiple sclerosis relates to disabilityon February 27, 2020 at 2:32 am
Structural network-based approaches can assess white matter connections revealing topological alterations in multiple sclerosis (MS). However, principal network (PN) organisation and its clinical ...
- Multiple Sclerosis (MS) Drugs Market to See Massive Growth by 2025 | Bayer, Bayhill Therapeutics, Biogenon February 27, 2020 at 12:25 am
Global Multiple Sclerosis (MS) Drugs Market Analysis 2015-2019 and Forecast 2020-2025 is latest research study released by HTF MI evaluating the market, highlighting opportunities, risk side analysis, ...
- Multi-sensor band quickly and simply records subtle changes in patients with multiple sclerosison February 26, 2020 at 11:54 pm
Multiple sclerosis (MS) is a progressive, chronic disorder in which the body's immune system attacks the central nervous system, resulting in multiple adverse effects, from numbness, fatigue and ...
- Fifth and Final Site Announced for BrainStorm's Progressive Multiple Sclerosis Phase 2 Clinical Trialon February 26, 2020 at 10:00 pm
BrainStorm Cell Therapeutics Inc. BCLI, -17.68%, a leader in developing innovative autologous cellular therapies for highly debilitating neurodegenerative diseases, today announced that Partners MS ...
- Selma Blair Shared How She Found ‘Hope’ After Her Multiple Sclerosis Diagnosison February 26, 2020 at 3:45 pm
In recent years, Blair has become notorious for another reason — her revelation of her multiple sclerosis diagnosis. With friends and fans rallying around Blair as she battles her illness, the actress ...
- Learning to Live With Multiple Sclerosison February 26, 2020 at 2:07 pm
In 2014, Meredith O’Brien was diagnosed with relapse-remitting multiple sclerosis. The author, teacher, wife, and mother had spent more than two years seeking help for symptoms that were scary, ...
- Antioxidant precursor molecule could improve brain function in patients with multiple sclerosison February 26, 2020 at 10:08 am
N-acetylcysteine (NAC) is a naturally occurring molecule that replenishes antioxidants and shows improved brain metabolism and self-reported improvements in cognitive function in patients with ...
- Even doctors miss early signs of multiple sclerosison February 25, 2020 at 4:38 pm
There’s no cure for Multiple sclerosis, but an early diagnosis can help doctors treat the unpredictable disease.
- Multiple Sclerosis Made Me Strongeron February 25, 2020 at 12:12 pm
If you’re among the one million Americans living with multiple sclerosis, you know it's a lot, physically and emotionally. But for many people with MS, the condition also becomes a new source of ...
- Wok Hard fundraiser at Congregation Sinai offers a Chinese meal, helps fight multiple sclerosison February 25, 2020 at 1:05 am
A chance to eat well and do good: Wok Hard to Fight MS will be Feb. 29 at Congregation Sinai in Fox Point. The event has a new name this year but the same mission: to raise money to find a cure for ...
via Bing News